erythromycin has been researched along with Cystadenocarcinoma in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fiorica, JV; Flannery, MT; Hoffman, MS; Love, SR; Wallach, PM | 1 |
1 other study(ies) available for erythromycin and Cystadenocarcinoma
| Article | Year |
|---|---|
Erythromycin associated hearing loss in a patient with prior cis-platinum induced ototoxicity.
Topics: Cisplatin; Cystadenocarcinoma; Erythromycin; Female; Hearing Loss, High-Frequency; Hearing Loss, Sensorineural; Humans; Injections, Intravenous; Middle Aged; Ovarian Neoplasms | 1992 |